Document Detail


beta-Agonist tocolytic therapy.
MedLine Citation:
PMID:  16125044     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
With the advent of preterm birth prevention programs, increasing numbers of patients are now considered candidates for tocolytic management. Tocolysis' chief benefit is significantly prolonging pregnancy in the hope of avoiding or ameliorating the sequelae of preterm delivery. Three principal indications dominate the use of tocolysis in the treatment of preterm labor: (1) prophylaxis, (2) acute therapy, and (3) maintenance.
Authors:
Fung Lam; Pamela Gill
Related Documents :
10907564 - Antenatal phenobarbital for prevention of intraventricular hemorrhage in preterm infants.
17437224 - Amino acids in amniotic fluid in the 15th-16th weeks of gestation and preterm labor.
9690274 - Intergenerational influences affecting birth outcome. ii. preterm delivery and gestatio...
12118654 - Algorithms for combining menstrual and ultrasound estimates of gestational age: consequ...
15140504 - Obstetrical complications and subsequent schizophrenia in adolescent and young adult of...
19394924 - Chronic exposure to fine particulate matter emitted by traffic affects reproductive and...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Obstetrics and gynecology clinics of North America     Volume:  32     ISSN:  0889-8545     ISO Abbreviation:  Obstet. Gynecol. Clin. North Am.     Publication Date:  2005 Sep 
Date Detail:
Created Date:  2005-08-29     Completed Date:  2005-10-28     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  8709551     Medline TA:  Obstet Gynecol Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  457-84     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, California Pacific Medical Center, San Francisco, 94118, USA. funglamMD@aol.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Agonists / administration & dosage,  adverse effects,  therapeutic use*
Female
Humans
Infusion Pumps, Implantable
Obstetric Labor, Premature / drug therapy*
Pregnancy
Terbutaline / administration & dosage
Tocolytic Agents / therapeutic use*
Chemical
Reg. No./Substance:
0/Adrenergic beta-Agonists; 0/Tocolytic Agents; 23031-25-6/Terbutaline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Preterm labor in twins and high-order multiples.
Next Document:  Magnesium sulfate: the first-line tocolytic.